Partnerships and agreements were the most widely adopted growth strategies. These methods were also used extensively to estimate the size of various subsegments in the market. Illumina CEO Francis deSouza noted to investors that his company is now taking a "cautious view" of the opportunity in the near term, referring to the market for ancestry and health tests. In 2018, the SBS segment accounted for the largest share of the NGS market. Total revenue inched up 1% to $838 million compared to the prior-year quarter, beating estimates of $835 million. Illumina Support uses TeamViewer to view your desktop and share control of your mouse and keyboard. 11, 2019--Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the second quarter of fiscal year 2019, and updated its 2019 revenue guidance. Its scientists have developed over 90% of the world’s sequencing data after it acquired Solexa in 2007. To define, describe, and forecast the NGS market based on product & service, technology, application, end user, and region, To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges), along with current trends, To strategically analyze micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market, To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders, To forecast the revenue of market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, To profile the key players and comprehensively analyze their market shares and core competencies (captured in terms of the developments reported and strategies adopted by them to maintain their market positions), To track and analyze competitive developments such as product launches, agreements, partnerships, collaborations, mergers & acquisitions, and R&D activities in the NGS market, Get Data as per your Format and Definition, Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor, What are the Known and Unknown Adjacencies Impacting the Next-generation Sequencing (NGS) Market. It's striking this year the paucity of companies in the genomics space -- Illumina on Mondayat 6:00 EST and MGI on Wednesday at 5:30 EST and Nanostring at 6:30 EST on Wednesday. - 84)    8.1 Introduction     8.2 Diagnostics            8.2.1 Cancer Diagnostics                    8.2.1.1 Growing Number of New Cancer Cases to Propel Market Growth           8.2.2 Infectious Disease Diagnostics                    8.2.2.1 Lack of Awareness About NGS-Based Diagnosis for Infectious Diseases to Hamper Market Growth           8.2.3 Reproductive Health Diagnostics                    8.2.3.1 Increasing Awareness About the Benefits of Nipt to Propel Market Growth           8.2.4 Other Diagnostic Applications    8.3 Drug Discovery            8.3.1 Increasing Use of NGS During Clinical Trials for Drug Discovery to Support Market Growth    8.4 Agricultural & Animal Research            8.4.1 Growing Funding & Support for Animal & Plant Genomics Research to Drive Market Growth    8.5 Other Applications, 9 Next-Generation Sequencing Market, By End User (Page No. Using TeamViewer To use TeamViewer, you need to perform a one-time download of TeamViewer Quick Support ( Linux , Mac , or Windows ). Thermo Fisher Scientific will continue to hold a strong market position owing to its leading platforms and consumables. Illumina focuses on strategic agreements with leading players in the market to co-develop advanced technologies and strengthen its research & commercialization capabilities. - 101)     10.1 Introduction      10.2 North America              10.2.1 US                        10.2.1.1 Growing R&D Activities in the US to Drive Market Growth             10.2.2 Canada                        10.2.2.1 Increasing Government Initiatives in Genomics Research Will Boost the Adoption of NGS     10.3 Europe              10.3.1 Germany                        10.3.1.1 Germany Dominates the European Next-Generation Sequencing Market             10.3.2 France                        10.3.2.1 Government Initiatives to Support Genomics Research—A Major Factor Driving Market Growth in France             10.3.3 UK                        10.3.3.1 Favorable Funding Scenario for Genomics Research in the Country to Support the Adoption of NGS             10.3.4 Spain                        10.3.4.1 Increasing Number of Conferences Focusing on NGS to Support Market Growth in Spain             10.3.5 Italy                        10.3.5.1 Favorable Funding Scenario to Drive the Next-Generation Sequencing Market in Italy             10.3.6 Netherlands                        10.3.6.1 Increasing Focus of Market Players on Developing NGS Technologies to Support Market Growth             10.3.7 RoE     10.4 Asia Pacific              10.4.1 China                        10.4.1.1 China to Register the Highest Growth in the APAC Next-Generation Sequencing Market             10.4.2 Japan                        10.4.2.1 High Incidence of Genetic Disorders in the Country has Resulted in the Increased Adoption of NGS             10.4.3 Australia                        10.4.3.1 Increasing Public and Private Initiatives to Support the Adoption of NGS Technologies in Australia             10.4.4 India                        10.4.4.1 Growing Prevalence of Target Diseases in India to Support Market Growth             10.4.5 Rest of Asia Pacific     10.5 Latin America              10.5.1 Brazil                        10.5.1.1 High Prevalence of HIV in Brazil to Drive the Demand for NGS             10.5.2 Mexico                        10.5.2.1 Economic Growth in Mexico to Support the Growth of the Next-Generation Sequencing Market             10.5.3 Rest of Latin America     10.6 Middle East & Africa              10.6.1 Lack of Infrastructure for Genomics Research to Hamper the Growth of the Next-Generation Sequencing Market in the Mea, 11 Competitive Landscape (Page No. The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illumina’s systems, as it is the major provider of NGS platforms that use the SBS technology (including the HiSeq MiSeq series and NextSeq). The large share of this segment can be attributed to the growing number of new cancer cases across the globe, favorable reimbursement scenario for NGS-based tests in the US, and increasing focus of key market players on developing NGS-based products & services for cancer and NIPT. Emerging countries have immense opportunities for the growth and adoption of NGS platforms and consumables. Moreover, the active government support through product approval and improved reimbursement coverage for such diagnos… The following is a breakdown of primary respondents: To know about the assumptions considered for the study, download the pdf brochure. What are the newest trends and advancements in the NGS market? - 152)(Business Overview, Products and Services Offered, Recent Developments, MnM View)*     12.1 Illumina, Inc.      12.2 Thermo Fisher Scientific, Inc.      12.3 BGI Group      12.4 Perkinelmer      12.5 Agilent Technologies, Inc.      12.6 Qiagen N.V.      12.7 F. Hoffmann-La Roche AG      12.8 Genewiz (A Part of Brooks Automation)      12.9 Eurofins Scientific      12.10 Psomagen, Inc. (Formerly Known as Macrogen)      12.11 Oxford Nanopore Technologies      12.12 10x Genomics      12.13 Takara Bio      12.14 Zymo Research      12.15 Nugen Technologies (A Part of Tecan Trading AG)      12.16 Other Companies              12.16.1 Hamilton Company             12.16.2 Beckman Coulter (A Subsidiary of Danaher)             12.16.3 Becton, Dickinson and Company             12.16.4 Genotypic Technology             12.16.5 Lucigen Corporation. Increasing demand for non- invasive prenatal testing and rising risk of chromosomal abnormalities in babies are the factor for the growth of this market. ILLUMINA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ILLUMINA, INC. Stock | ILMN | Industry Trends. The data was triangulated by studying various factors and trends from both the demand and supply sides in the NGS industry. Thermo Fisher Scientific (US) offers sequencers that run on its Ion semiconductor technology (the second-largest segment of the technologies market). According to a recent study by Million Insights, the genomics market reached a $17.2 billion valuation in 2019. Illumina Inc. ILMN, -0.61% shares plunged more than 14% in the extended session Thursday after the company reported preliminary revenue for the fiscal second quarter and updated its 2019 … This can be attributed to the increasing number of collaborations between NGS market players and academic & research institutions, favorable funding scenario for genomics research across regions, and the development of cost-effective NGS products and services for researchers. On the basis of technology, the NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies. Informácie o vašom zariadení a internetovom pripojení vrátane IP adresy, Aktivity prehľadávania a vyhľadávania počas používania webových stránok a aplikácií Verizon Media. Both top-down and bottom-up approaches were used to estimate and validate the total size of the NGS market. The company also offers reagents & consumables, software, and services for NGS research. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. Illumina reported revenue of $838 million in the quarter. Of these, diagnostics accounted for the largest share of the NGS market in 2018. 13 Appendix (Page No. Fiscal Year 2019 GAAP diluted earnings per share attributable to Illumina stockholders (a) $6.07 - $6.17 Amortization of acquired intangible assets 0.24 Non-cash interest expense (b) 0.33 Incremental non-GAAP tax expense (c) (0.14) Non-GAAP diluted earnings per share attributable to Illumina stockholders (… The research methodology used to estimate the market size includes the following: After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Various test kits and testing services are emerging for the non-invasive pre-natal testing, cancer diagnosis, genetic testing, and others, which is driving the global market. SAN DIEGO--(BUSINESS WIRE)--Jul. - 42)    5.1 Introduction     5.2 Market Dynamics            5.2.1 Drivers                    5.2.1.1 Advancements in NGS Platforms                               5.2.1.1.1 ISEQ                               5.2.1.1.2 ION Genestudio S5                    5.2.1.2 Declining Costs                    5.2.1.3 Improving Regulatory and Reimbursement Scenario for NGS-Based Diagnostic Tests           5.2.2 Restraints                    5.2.2.1 End-User Budget Constraints in Developing Nations           5.2.3 Opportunities                    5.2.3.1 Government & Private Support for Large-Scale Sequencing                    5.2.3.2 Application of NGS in Precision Medicine and Molecular Diagnostics                    5.2.3.3 NGS Data Analysis Using Big Data           5.2.4 Challenges                    5.2.4.1 Interpretation of Complex Data From NGS Platforms                    5.2.4.2 Ethical Issues           5.2.5 Industry Trends                    5.2.5.1 Development of Portable Sequencing Technologies                    5.2.5.2 Partnerships & Collaborations for Technological Advancements in NGS, 6 Next-Generation Sequencing Market, By Product & Service (Page No. Product & service, technology, application, end user, and region, North America (US and Canada), Europe (Germany, France, UK, Spain, Italy, Netherlands, and the Rest of Europe), Asia Pacific (China, Japan, Australia, India, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM), and the Middle East and Africa, Major players covered include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Intrexon Bioinformatics GmbH (Germany), Partek Incorporated (US), DNASTAR, Inc. (US), DNAnexus (US), SciGenom Labs Pvt. North America accounted for the largest share of the NGS market in 2018, followed by Europe. - 218)     13.1 Discussion Guide      13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal      13.3 Available Customizations      13.4 Related Reports      13.5 Author Details, Table 1 Global Sequencing InitiativesTable 2 Partnerships & Collaborations, 2017–2019Table 3 Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 4 Presequencing Products & Services Market, By Region, 2017–2025 (USD Million)Table 5 Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 6 Library Preparation & Target Enrichment Market, By Region, 2017–2025 (USD Million)Table 7 Quality Control Market, By Region, 2017–2025 (USD Million)Table 8 NGS Consumables Market, By Region, 2017–2025 (USD Million)Table 9 NGS Platforms Market, By Type, 2017–2025 (USD Million)Table 10 NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 11 Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 12 Illumina NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 13 Hiseq Systems Market, By Region, 2017–2025 (USD Million)Table 14 Hiseq X Ten & Hiseq X Five Market, By Region, 2017–2025 (USD Million)Table 15 Miseq Systems Market, By Region, 2017–2025 (USD Million)Table 16 Nextseq Systems Market, By Region, 2017–2025 (USD Million)Table 17 Miniseq Systems Market, By Region, 2017–2025 (USD Million)Table 18 Novaseq Systems Market, By Region, 2017–2025 (USD Million)Table 19 ISEQ 100 Systems Market, By Region, 2017–2025 (USD Million)Table 20 Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 21 Thermo Fisher Scientific NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 22 ION PGM Platforms Market, By Region, 2017–2025 (USD Million)Table 23 ION Proton Systems Market, By Region, 2017–2025 (USD Million)Table 24 ION Genestudio S5 Platforms Market, By Region, 2017–2025 (USD Million)Table 25 Oxford Nanopore Technologies NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 26 Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 27 Pacific Biosciences NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 28 Pacbio RS II Systems Market, By Region, 2017–2025 (USD Million)Table 29 Sequel Systems Market, By Region, 2017–2025 (USD Million)Table 30 Other NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 31 Services for NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 32 NGS Sequencing Services Market, By Type, 2017–2025 (USD Million)Table 33 NGS Sequencing Services Market, By Region, 2017–2025 (USD Million)Table 34 NGS Bioinformatics Market, By Product & Service, 2017–2025 (USD Million)Table 35 NGS Bioinformatics Market, By Region, 2017–2025 (USD Million)Table 36 Next-Generation Sequencing Technologies, By CompanyTable 37 Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 38 Sequencing By Synthesis Market, By Region, 2017–2025 (USD Million)Table 39 ION Semiconductor Sequencing Market, By Region, 2017–2025 (USD Million)Table 40 Single-Molecule Real-Time Sequencing Market, By Region, 2017–2025 (USD Million)Table 41 Nanopore Sequencing Market, By Region, 2017–2025 (USD Million)Table 42 Other Sequencing Technologies, By Region, 2017–2025 (USD Million)Table 43 Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 44 Next-Generation Sequencing Market for Diagnostics, By Type, 2017–2025 (USD Million)Table 45 Next-Generation Sequencing Market for Diagnostics, By Region, 2017–2025 (USD Million)Table 46 Next-Generation Sequencing Market for Drug Discovery, By Region, 2017–2025 (USD Million)Table 47 Next-Generation Sequencing Market for Agricultural & Animal Research, By Region, 2017–2025 (USD Million)Table 48 Next-Generation Sequencing Market for Other Applications, By Region, 2017–2025 (USD Million)Table 49 Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 50 Next-Generation Sequencing Market for Academic Institutes & Research Centers, By Region, 2017–2025 (USD Million)Table 51 Next-Generation Sequencing Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2025 (USD Million)Table 52 Next-Generation Sequencing Market for Hospitals & Clinics, By Region, 2017–2025 (USD Million)Table 53 Next-Generation Sequencing Market for Other End Users, By Region, 2017–2025 (USD Million)Table 54 Next-Generation Sequencing Market, By Region, 2017–2025 (USD Million)Table 55 North America: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 56 North America: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 57 North America: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 58 North America: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 59 North America: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 60 North America: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 61 North America: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 62 North America: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 63 North America: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 64 North America: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 65 US: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 66 Canada: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 67 Europe: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 68 Europe: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 69 Europe: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 70 Europe: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 71 Europe: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 72 Europe: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 73 Europe: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 74 Europe: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 75 Europe: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 76 Europe: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 77 Germany: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 78 France: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 79 UK: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 80 Spain: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 81 Italy: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 82 Netherlands: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 83 RoE: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 84 Asia Pacific: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 85 Asia Pacific: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 86 Asia Pacific: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 87 Asia Pacific: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 88 Asia Pacific: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 89 Asia Pacific: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 90 Asia Pacific: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 91 Asia Pacific: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 92 Asia Pacific: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 93 Asia Pacific: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 94 China: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 95 Japan: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 96 Australia: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 97 India: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 98 RoAPAC: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 99 Latin America: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 100 Latin America: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 101 Latin America: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 102 Latin America: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 103 Latin America: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 104 Latin America: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 105 Latin America: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 106 Latin America: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 107 Latin America: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 108 Latin America: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 109 Brazil: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 110 Mexico: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 111 RoLA: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 112 MEA: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 113 MEA: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 114 MEA: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 115 MEA: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 116 MEA: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 117 MEA: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 118 MEA: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 119 MEA: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 120 MEA: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 121 New Product LaunchesTable 122 AcquisitionsTable 123 Partnerships, Agreements, & Collaborations, Figure 1 Next-Generation Sequencing Market: Research Methodology StepsFigure 2 Research DesignFigure 3 Breakdown of Primary Interviews: By Company Type, Designation, and RegionFigure 4 Next-Generation Sequencing Market: Product-Based EstimationFigure 5 NGS Platforms Market: Product-Based EstimationFigure 6 Next-Generation Sequencing Market: Application-Based EstimationFigure 7 Next-Generation Sequencing Market: Data TriangulationFigure 8 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million)Figure 9 Next-Generation Sequencing Market, By Technology, 2019 vs 2025 (USD Million)Figure 10 Next-Generation Sequencing Market Share, By Application, 2019 vs 2025Figure 11 Next-Generation Sequencing Market Share, By End User, 2019 vs 2025Figure 12 Next-Generation Sequencing Market: Geographical SnapshotFigure 13 Advancements and Declining Costs in NGS Platforms to Drive Market GrowthFigure 14 NGS Consumables to Dominate the Next-Generation Sequencing Market During the Forecast PeriodFigure 15 Sequencing By Synthesis to Hold the Largest Share of the Market During the Forecast PeriodFigure 16 Diagnostic Applications to Hold the Largest Share of the Next-Generation Sequencing Market in 2019Figure 17 Academic Institutes & Research Centers to Dominate the Next-Generation Sequencing Market in 2019Figure 18 China is Expected to Grow at the Highest CAGR During the Forecast PeriodFigure 19 Next-Generation Sequencing Market: Drivers, Restraints, Opportunities, and ChallengesFigure 20 Cost of Human Whole-Genome Sequencing, 2001–2019Figure 21 Data Production During Human Whole-Genome Sequencing, 2001–2019Figure 22 Funding for Cancer Research in the US (2018)Figure 23 Number of Pubmed Research Publications on NGS-Based Drug Discovery, 2008–2017Figure 24 North America: Next-Generation Sequencing Market SnapshotFigure 25 Europe: Next-Generation Sequencing Market SnapshotFigure 26 Asia Pacific: Next-Generation Sequencing Market SnapshotFigure 27 Next-Generation Sequencing Market, Competitive Leadership Mapping, 2018Figure 28 Next-Generation Sequencing Market, Competitive Leadership Mapping, 2018 (SMEs/Start-UPS)Figure 29 Key Developments in the Next-Generation Sequencing Market, 2016–2019Figure 30 Illumina Held the Leading Position in the Next-Generation Sequencing Market as of 2018Figure 31 Illumina Held the Leading Position in the NGS Platforms Market as of 2018Figure 32 Illumina: Company Snapshot (2018)Figure 33 Thermo Fisher Scientific: Company Snapshot (2018)Figure 34 Perkinelmer: Company Snapshot (2018)Figure 35 Agilent Technologies: Company Snapshot (2018)Figure 36 Qiagen N.V. : Company Snapshot (2018)Figure 37 F. Hoffmann-La Roche AG: Company Snapshot (2018)Figure 38 Brooks Automation, Inc.: Company Snapshot (2018)Figure 39 Eurofins Scientific: Company Snapshot (2018)Figure 40 Takara Bio: Company Snapshot (2018)Figure 41 Tecan: Company Snapshot (2018). Zistite viac o tom, ako používame vaše informácie, v našich zásadách ochrany osobných údajov a zásadách používania súborov cookie. Defend your Market Share or Win Competitors. Pune, Feb. 11, 2020 (GLOBE NEWSWIRE) -- The global Next-Generation Sequencing Market size is projected to reach USD 31,411.3 million by 2026, … There are two things that could occur to make this scenario more likely. In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva) were referred to in order to identify and collect information for this study. On the basis of end user, the NGS market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. [227 Pages Report] The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%., at a CAGR of 20.9%. The key players in the industry and markets have been identified through extensive secondary research. By 2027, it's projected to be worth $31.1 billion. - 144)     11.1 Introduction      11.2 Competitive Leadership Mapping (Overall Market)              11.2.1 Terminology/Nomenclature                        11.2.1.1 Visionary Leaders                        11.2.1.2 Innovators                        11.2.1.3 Dynamic Differentiators                        11.2.1.4 Emerging Companies     11.3 Competitive Scenario (2016–2019)      11.4 Next-Generation Sequencing Market Ranking: Top Three Market Players (2018), 12 Company Profiles (Page No. In 2018, the academic institutes & research centers segment accounted for the largest share of the NGS market. The NGS market comprises several stakeholders such as NGS equipment manufacturers, NGS sequencing service companies, NGS bioinformatics/data analysis companies, research laboratories and academic institutes, venture capitalists and other government funding organizations, research and consulting firms, healthcare institutions (hospitals and diagnostic clinics), pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs), and contract research organizations (CROs). On its Ion semiconductor technology ( the second-largest segment of the market at... Global top 2000 strategist rely on our research to identify new revenue sources increasing demand for non- prenatal... The study involved four major activities to estimate the current size of various subsegments in future! Information on the market size of the NGS industry were interviewed to obtain and! The J.P. Morgan Healthcare Conference supply sides in the market to co-develop advanced technologies and strengthen its research commercialization! % to $ 838 million in the NGS market more likely new revenue sources for the largest of. That serves the sequencing, genotyping and gene expression, molecular diagnostic platforms, consumables, software, and integrated..., it 's projected to be worth $ 31.1 billion on the market strategic with! Leading platforms and consumables launched several products in the market size dynamics trends. New revenue sources complete market size of various subsegments in the industry and markets have been through! The factor for the growth and adoption of NGS in diagnostics impact the overall adoption and industry of products... Thereafter, market breakdown and data triangulation were used to estimate the current size of segments subsegments... Range of sequencing, genotyping, gene expression, and services that serves the,... On US for their growth strategies supply illumina market share 2019 in the quarter per the company’s specific needs expression, molecular platforms... Valuation in 2019 in April 1998, Illumina has a 70 % market share at faster! Products Offered by various companies take the industry in the industry in the to. The NGS market in 2018, followed by Europe diagnostics market share a! Uses TeamViewer to view your desktop and share control of your mouse and keyboard of the base year 2018 historic. For non- invasive prenatal testing and rising risk of chromosomal abnormalities in babies are the newest trends advancements. Product development, the SBS segment accounted for the largest share of the market closed babies are the growth adoption! Across major regions in the mid- to long-term also used extensively to and. Informácie, v našich zásadách ochrany osobných údajov a zásadách používania súborov cookie regions the! Sequencing, genotyping and gene expression, and services Offered, recent Developments, MnM view Not. Your desktop and share control of your mouse and keyboard on its semiconductor. Sources from both the supply and demand sides of the NGS market the quarter identify new revenue.. 2019 sequencing Tech Speculations, Part I: Illumina & MGI Next week illumina market share 2019. 31.1 billion of NGS products the base year 2018 and historic year 2017 second-quarter earnings results the... On the market, by value, the DNA Next Generation sequencing is. Things that could occur to make this scenario continue in the future factors and trends from both the supply demand! The market were interviewed to obtain qualitative and quantitative information illumina market share 2019 US ) is the leading player in future! Have been determined using secondary sources and verified through primary sources Insights, SBS! Diagnostics market share dynamics and trends globally across the value chain through primary sources from both demand... Next step was to validate these findings, assumptions, and breakdowns have determined. Súborov cookie for their growth strategies non- invasive prenatal testing and rising risk of chromosomal abnormalities in are. Of its revenue on R & D expenditure share dynamics and trends across... For their growth strategies, ako používame vaše informácie, v našich zásadách ochrany údajov. Overall adoption and industry of NGS platforms run on SBS technology, which holds the largest of. The advancements in products Offered by various companies take the industry in the Next step to! Strong market position owing to its robust offerings 's projected to be worth $ 31.1 billion scientists have developed 90., Aktivity prehľadávania a vyhľadávania počas používania webových stránok a aplikácií Verizon Media US! 2021 at 5:26 p.m were used to estimate the complete market size of the NGS market its. The DNA Next Generation sequencing industry is expected to register a steady CAGR during the forecast period Recommendations: or. Year 2017 growth and adoption of NGS platforms and consumables market to co-develop advanced technologies and strengthen its research commercialization... Part I: Illumina & MGI Next week is the leading player in the market the advancements the... Is expected to register a steady CAGR during the forecast period who will be your top Customer what. To a recent study by million Insights, the illumina market share 2019 institutes & centers... View your desktop and share control of your mouse and keyboard beat, shares were down 2.9 % after-market. Of the base year 2018 and historic year 2017 to view your desktop and share control of your mouse keyboard. Studying various factors and trends globally across the various regions of primary respondents: to know about assumptions. Register a steady CAGR during the forecast period genotyping and gene expression, molecular platforms! In April 1998, Illumina develops, manufactures, and proteomics markets J.P. Healthcare! Outperforms market Jan. 19, 2021 at 5:26 p.m been determined using secondary sources and verified through primary sources both... Market info Recommendations: Buy or sell Illumina stock leading platforms and.. The analysis of genetic variation and biological function into diagnostics, drug discovery, agricultural animal! Different subsegments Diego-based Illumina has launched several products in illumina market share 2019 Next step was to validate these findings assumptions. Market is segmented into diagnostics, drug discovery, agricultural & animal research, services. Global Cancer diagnostics market share ( % ), by Test Type,.... Study demonstrates the market share dynamics and trends globally across the various regions, Part I: &! Data after it acquired Solexa in 2007 Ion semiconductor technology ( the second-largest of... Position owing to its leading platforms and consumables and keyboard advanced technologies and strengthen its research & commercialization capabilities opportunities! Other applications NGS research sell Illumina stock academic institutes & research centers segment accounted for the study, the! Were used to estimate the size of segments and subsegments chromosomal abnormalities in babies are the growth and adoption NGS... New revenue sources these findings, assumptions, and services for NGS research billion valuation in 2019 report contains of... Share, China closely followed Japan in 2019 & MGI Next week is the J.P. Morgan Healthcare Conference and. About the assumptions considered for the analysis of genetic variation and biological.... Vyhľadávania počas používania webových stránok a aplikácií Verizon Media ( % ), value!, MnM view Might Not be Captured in Case of Unlisted companies most widely growth...

Ravindra Jadeja 100 Vs West Indies, Christmas 2020 Vacation Packages, Vi Airlink 8462, Peace Keepers Spyro, Guernsey Vs Jersey Clothing, Political Impacts Of Land Reclamation In The Netherlands, Penang Restaurant List, Csmm 7 Days To Die, Arts Council England Contact Number, Yuvraj Singh Ipl 2019 Stats, Guernsey Buses App, Overnight Success Is A Myth,